Prevention of stretch marks in pregnancy: a pilot trial
- Conditions
- Striae gravidarumPregnancy and Childbirth
- Registration Number
- ISRCTN76992326
- Lead Sponsor
- ational University of Ireland Galway
- Brief Summary
2018 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/30314504 2020 qualitative study of the factors influencing recruitment in https://www.ncbi.nlm.nih.gov/pubmed/32050916 (added 14/02/2020)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped
- Sex
- Female
- Target Recruitment
- 40
1. Primigravid women
2. Singleton pregnancy
3. 12-14 weeks gestation at time of recruitment; updated 13/07/2018: 12-16 weeks gestation at time of recruitment
4. Absence of abdominal striae
5. Aged 18 or over at recruitment
6. English speaking women
1. Multigravid women (due to risk of having striae from an earlier pregnancy)
2. Women taking corticosteroids for any reason (due to their association with skin striae)
3. Multiple pregnancy (due to increased maternal weight gain and skin stretching)
4. Women with a known hypersensitivity to agents in baby oil (due to risk of allergic reaction)
5. Women with known disorders or illnesses that may be associated with striae, e.g., Marfan syndrome, Cushing syndrome
6. Women who decline to discontinue other creams or lotions
7. Women who are unable to give informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method